Literature DB >> 7799166

Immunization against Taenia crassiceps cysticercosis: identification of the most promising antigens in the induction of protective immunity.

F Valdez1, M Hernández, T Govezensky, G Fragoso, E Sciutto.   

Abstract

Cross immunity between Taenia solium and Taenia crassiceps parasites points to T. crassiceps cysticercosis as a convenient model to test promising antigens aimed at the development of a vaccine against T. solium cysticercosis. Since total antigens from T. crassiceps metacestodes induce significant levels of protection in pigs against T. solium cysticercosis, we initiated this work to identify the most interesting antigens involved in protection. Twelve different antigen fractions isolated from T. crassiceps cysticerci were evaluated with respect to their capacity to induce resistance against a challenge with 10 T. crassiceps cysticerci in male BALB/cAnN mice. Mice were intraperitoneally immunized with 2 doses of each antigen, 5 or 15 micrograms per mouse. The 12 antigen fractions were classified as protecting (200, 123, 74, 66, 56, 40-50, 27 and 8-14 kDa), facilitating (220-205 kDa), or irrelevant (150-160, 93, 108 kDa), according to their effect on the parasite load. The 3 most promising antigen fractions were reevaluated via subcutaneous immunization with Freund's complete adjuvant. A high level of protection was obtained when antigen fractions of 56, 66, and 74 kDa were used together. Interestingly, antigens with similar molecular weights were also detected in early steps of differentiation in T. solium cysticercosis. These observations may be helpful in the development of a synthetic or a recombinant vaccine against cysticercosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7799166

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  8 in total

1.  Towards a Taenia solium cysticercosis vaccine: an epitope shared by Taenia crassiceps and Taenia solium protects mice against experimental cysticercosis.

Authors:  A Toledo; C Larralde; G Fragoso; G Gevorkian; K Manoutcharian; M Hernández; G Acero; G Rosas; F López-Casillas; C K Garfias; R Vázquez; I Terrazas; E Sciutto
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Cysticercus antigens in cerebrospinal fluid samples from patients with neurocysticercosis.

Authors:  A X Pardini; A J Vaz; L Dos Ramos Machado; J A Livramento
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

3.  Experimental and Theoretical Approaches To Investigate the Immunogenicity of Taenia solium-Derived KE7 Antigen.

Authors:  Raúl J Bobes; José Navarrete-Perea; Adrián Ochoa-Leyva; Víctor Hugo Anaya; Marisela Hernández; Jacquelynne Cervantes-Torres; Karel Estrada; Filiberto Sánchez-Lopez; Xavier Soberón; Gabriela Rosas; Cáris Maroni Nunes; Martín García-Varela; Rogerio Rafael Sotelo-Mundo; Alonso Alexis López-Zavala; Goar Gevorkian; Gonzalo Acero; Juan P Laclette; Gladis Fragoso; Edda Sciutto
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

4.  Use of Taenia crassiceps cysticercus antigen preparations for detection of antibodies in cerebrospinal fluid samples from patients with neurocysticercosis (Taenia solium).

Authors:  Alessandra Xavier Pardini; Regina Helena Peralta; Adelaide José Vaz; Luis dos Ramos Machado; José Mauro Peralta
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

5.  Two epitopes shared by Taenia crassiceps and Taenia solium confer protection against murine T. crassiceps cysticercosis along with a prominent T1 response.

Authors:  A Toledo; G Fragoso; G Rosas; M Hernández; G Gevorkian; F López-Casillas; B Hernández; G Acero; M Huerta; C Larralde; E Sciutto
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

6.  Depressed T-cell proliferation associated with susceptibility to experimental Taenia crassiceps infection.

Authors:  E Sciutto; G Fragoso; M Baca; V De la Cruz; L Lemus; E Lamoyi
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

Review 7.  Fact or hypothesis: Taenia crassiceps as a model for Taenia solium, and the S3Pvac vaccine.

Authors:  M W Lightowlers
Journal:  Parasite Immunol       Date:  2010 Nov-Dec       Impact factor: 2.280

Review 8.  Disordered epitopes as peptide vaccines.

Authors:  Christopher A MacRaild; Jeffrey Seow; Sreedam C Das; Raymond S Norton
Journal:  Pept Sci (Hoboken)       Date:  2018-04-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.